Clinical Trials Directory

Trials / Completed

CompletedNCT01343160

Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures

Multicenter Study of Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
W.L.Gore & Associates · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to generate clinical data to support the use of GORE® VIABIL® Biliary Endoprosthesis in the endoscopic and percutaneous treatment of benign biliary strictures.

Conditions

Interventions

TypeNameDescription
DEVICEGORE® VIABIL® Biliary EndoprosthesisDeployment of GORE® VIABIL® Biliary Endoprosthesis to the area of stricture

Timeline

Start date
2011-04-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2011-04-27
Last updated
2021-04-21
Results posted
2021-04-21

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01343160. Inclusion in this directory is not an endorsement.

Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures (NCT01343160) · Clinical Trials Directory